| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/11/2001 | EP1089963A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
| 04/11/2001 | EP1089766A2 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 04/11/2001 | EP1089762A1 Konjugat |
| 04/11/2001 | EP1089753A2 Use of a dipeptide for stimulating repair processes |
| 04/11/2001 | EP1089752A1 Alpha-keto oxadiazoles as serine protease inhibitors |
| 04/11/2001 | EP1089751A1 Adjuvant therapy |
| 04/11/2001 | EP1089749A1 Novel therapeutic agents for membrane transporters |
| 04/11/2001 | EP1089743A1 Composition containing sulfur hexafluoride and oxygen, for increasing or decreasing the body temperature of a patient |
| 04/11/2001 | EP1089742A2 Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein |
| 04/11/2001 | EP1089741A1 Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv |
| 04/11/2001 | EP1089740A1 TREATMENT OF $i(C. DIFFICILE) TOXIN B ASSOCIATED CONDITIONS |
| 04/11/2001 | EP1089734A2 Use of tempo and tempo derivatives for inducing cell death |
| 04/11/2001 | EP1089733A2 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
| 04/11/2001 | EP1089732A1 Compositions and methods for treating elevated blood cholesterol |
| 04/11/2001 | EP1089727A1 Liposomal formulations of busulphan |
| 04/11/2001 | EP1089726A2 Composition comprising ss-hydroxy-ss-methylbutyric acid and at least one amino acid |
| 04/11/2001 | EP1089723A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 04/11/2001 | EP1089722A1 Matrix-type transdermal patch for steroid hormones |
| 04/11/2001 | EP0963203A4 Mammalian tolloid-like gene and protein |
| 04/11/2001 | EP0775113B1 N-substituted azabicycloheptane derivatives useful as neuroleptics |
| 04/11/2001 | EP0710285B1 Analogues of an anti-thrombin polypeptide and process for their preparation |
| 04/11/2001 | CN1291239A Fermentative preparation process for cytostatics and crystal form thereof |
| 04/11/2001 | CN1291238A Process for obtaining of HMG-CO A reductase inhibitors of high purify |
| 04/11/2001 | CN1291235A Vaccines immunotherapeutics and method for using the same |
| 04/11/2001 | CN1291231A Human telomerase catalytic subunit |
| 04/11/2001 | CN1291230A Biotin-binding receptor molecules |
| 04/11/2001 | CN1291228A Enzyme catalyzed therapeutic agents |
| 04/11/2001 | CN1291198A Three-dimesional structures and models of Fc receptors and use thereof |
| 04/11/2001 | CN1291196A Nevol anti-estrogenic steroids, and associated pharmaceutical compositions and method of use |
| 04/11/2001 | CN1291190A 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonist |
| 04/11/2001 | CN1291188A Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia |
| 04/11/2001 | CN1291184A Cycloalkene derivatives, process for producing the same and use |
| 04/11/2001 | CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 04/11/2001 | CN1291105A Hapten-modified tumor cell membranes and preparation and method for using it |
| 04/11/2001 | CN1291104A A pharmaceutical preparation comprising an angiotension II2 type receptor agonist, and use thereof |
| 04/11/2001 | CN1291102A Pharmaceutical preparation for selectively supplementing oestrogen deficiency in the central nervous system |
| 04/11/2001 | CN1291099A Heterocyclic compounds, their, production and use |
| 04/11/2001 | CN1291096A Use of inhibitors for treatment of disorders related to RTK hyperfunction |
| 04/11/2001 | CN1291095A Chemical compounds |
| 04/11/2001 | CN1291094A Bicyclic pyrrole derivatives as MCP-1 inhibitor |
| 04/11/2001 | CN1291092A pharmaceutical Combinations containing tramadol |
| 04/11/2001 | CN1290703A New metal protease inhibitors, its preparing method and their medicinal composition containing them |
| 04/11/2001 | CN1290540A Chinese medicine suppository for refreshment and removing summer leat |
| 04/11/2001 | CN1290539A Chinese medicine suppository for carsickness |
| 04/11/2001 | CN1064362C Pyrimido [5,4-D] pyrimidines, medicine containing these compounds, their use and process for their production |
| 04/11/2001 | CN1064358C Benyl piperidine derivatives |
| 04/11/2001 | CN1064356C New piperazine, piperidine and 1,2,5,6-tetrahydropyridine compounds process for preparation thereof, and pharmaceutical composition containing them |
| 04/11/2001 | CN1064354C Trilcyclic benzazepine vasopressin antagnonists |
| 04/11/2001 | CN1064352C Novel cyloakyl derivatives and inhibitors of bone resorption and vitronection receptor antagonists |
| 04/11/2001 | CN1064351C Substituted indanylidineacetylguanidine, process for their paraparation, their use as medicaments ofdiagonstic and medicaments containing them |
| 04/11/2001 | CN1064350C Aryl and heteroaryl alkoxynaphtalene derivatives |
| 04/11/2001 | CN1064261C Ginseng royal jelly without delaminating deposition and its preparing method |
| 04/10/2001 | US6215002 Cyclization, deblocking, deprotection, sulfonation, condensation, amidation; antiinflammatory agents; respiratory system disorders |
| 04/10/2001 | US6214992 Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation |
| 04/10/2001 | US6214991 3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-n-acetic acid, ethyl ester for example; treating complications of diabetes mellitus, such as cataracts, retinopathy, nephropathy, and neuropathy |
| 04/10/2001 | US6214986 Antisense modulation of bcl-x expression |
| 04/10/2001 | US6214887 For preventing or treating hyperproliferative vascular disease |
| 04/10/2001 | US6214883 Benzamidoxime prodrugs as antipneumocystic agents |
| 04/10/2001 | US6214876 Indene-1-acetamide sPLA2 inhibitors |
| 04/10/2001 | US6214874 Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N |
| 04/10/2001 | US6214870 Antiarthritic agents; anticancer agents |
| 04/10/2001 | US6214862 Analyzing proteasome sensitivity proteolysis |
| 04/10/2001 | US6214858 Caspases and apoptosis |
| 04/10/2001 | US6214857 Substituted alkanohydroxamic acids and method of reducing TNFα levels |
| 04/10/2001 | US6214854 Administering adrenoceptor, or antagonist thereof; cardiovascular disorders |
| 04/10/2001 | US6214852 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 04/10/2001 | US6214848 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action for prophylaxis and treatment of diabetes; depressing diabetic hyperglycemia |
| 04/10/2001 | US6214846 Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents |
| 04/10/2001 | US6214844 Substituted imidazole compounds |
| 04/10/2001 | US6214839 Substituted 6-alkylphenanthridines |
| 04/10/2001 | US6214830 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 04/10/2001 | US6214829 Piperazine compounds, their preparation, and methods of using them |
| 04/10/2001 | US6214822 Substituted aza and diazacycloheptane and cyclooctane compounds and their use |
| 04/10/2001 | US6214808 Hemostatic agent |
| 04/10/2001 | US6214798 Polypeptides |
| 04/10/2001 | US6214795 Polypetides with amino acid sequences |
| 04/10/2001 | US6214614 Cell cycle regulated repressor and DNA element |
| 04/10/2001 | US6214600 Polypeptide of defined amino acid sequence; treatment of alzheimer's disease, stroke, musculoskeletal disease, heart disease, kidney disease; anticarcinogenic/antiinflammatory agents; antiarthritic agents; diagnosis |
| 04/10/2001 | US6214595 Enzymatic polypeptide for utilization in screening bactericides; wound healing agents; for prevent of bacterial wound infections |
| 04/10/2001 | US6214584 Nucleotide sequence which encodes polypeptide associated with immunocompetence; for use in the treatment and prevent of tumors, viral diseases, bacterial infections and autoimmune diseases |
| 04/10/2001 | US6214580 Nucleotide sequences coding binding protein associated with apoptosis; for detecting modulators of apoptosis; for treating cancers, sepsis, cachexia, autoimmune and viral diseases, inflammation, nervous system and liver disorders |
| 04/10/2001 | US6214567 Testing antitumor agents; obtain preferential human tissue and incubate with antitumor agent, evaluate propagtion of tumorous cells |
| 04/10/2001 | US6214562 Transcriptionally regualted G protein-coupled receptor |
| 04/10/2001 | US6214388 Immunoliposomes that optimize internalization into target cells |
| 04/10/2001 | US6214330 Polymeric-based double prodrugs having reversible linkages involving amino or hydroxyl moieties of chemical compounds and biologically active materials such as enzymes and proteins |
| 04/10/2001 | CA2165618C Tricyclic oxime ethers; process for preparing the same and pharmaceutical compositions containing them |
| 04/10/2001 | CA2162106C 5-(aryloxymethyl)oxazolines, process for preparing the same and pharmaceutical compositions containing them |
| 04/10/2001 | CA2133413C Indole derivatives as 5-ht1 antagonists |
| 04/10/2001 | CA2130436C Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
| 04/10/2001 | CA2117532C Method of inhibiting carcinogenesis by treatment with dehydropiandrosterone and analogs thereof |
| 04/10/2001 | CA2014695C Feed additive for cultivated fishes and feed for cultivated fishes |
| 04/10/2001 | CA1341212C Osteoinductive factors |
| 04/06/2001 | CA2322560A1 Corticoid therapy |
| 04/05/2001 | WO2001023592A2 Methods for making recombinant proteins using apoptosis inhibitors |
| 04/05/2001 | WO2001023584A1 Human ubiquitin protease |
| 04/05/2001 | WO2001023571A1 Methods and compositions relating to sodium channel beta1a subunits |
| 04/05/2001 | WO2001023570A2 Methods and compositions relating to sodium channel beta-1a subunits |
| 04/05/2001 | WO2001023565A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 04/05/2001 | WO2001023563A2 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
| 04/05/2001 | WO2001023554A1 The prv-1 gene and use thereof |